Suppression of anti-microtubule agent-induced apoptosis by nitric oxide: Possible mechanism of a new drug resistance

Japanese Journal of Cancer Research

Volumn 89, Issue 2, 1998, Pages 199-205

  Ogura, Tsutomu ^a   DeGeorge, George ^a,b   Tatemichi, Masayuki ^a   Esumi, Hiroyasu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Society for Promotion of Science

Author keywords

Anti microtubule agent; Apoptosis; ICE protease cascade; Nitric oxide

Indexed keywords

DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE; PACLITAXEL; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; MICROTUBULE; NEUROBLASTOMA CELL; NUCLEOSOME; PRIORITY JOURNAL;

EID: 0031939562     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00549.x     Document Type: Article

References (36)

1. Moscow, J. A. and Cowan, K. H. J. Multidrug resistance. J. Natl. Cancer Inst., 80, 14-20 (1988).
2. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M. and Pastan, I. Expression of multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84, 265-269 (1987).
3. Brewer, F. and Warr, J. R. Verapamil reversal of vincristine resistance and cross-resistance patterns of vincristine-resistant Chinese hamster ovary cells. Cancer Treat. Rep., 71, 353-359 (1987).
4. Da, S. C., De, O. C., Da, C. M. and De, L. P. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem. Pharmacol., 55, 1331-1340 (1996).
5. Geyp, M., Ireland, C. M. and Pittman, S. M. Resistance to apoptotic cell death in a drug resistant T cell leukaemia cell line. Leukemia, 10, 447-455 (1996).
6. Gangemi, R. M., Tiso, M., Marchetti, C., Severi, A. B. and Fabbi, M. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharm., 36, 385-392 (1995).
7. Messmer, U. K., Lapetina, E. G. and Brune, B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C-and protein kinase A-activating compounds. Mol. Pharmacol., 47, 757-765 (1995).
8. Ankarcrona, M., Dypbukt, J. M., Brune, B. and Nicotera, P. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res., 213, 172-177 (1994).
9. Blanco, F. J., Ochs, R. L., Schwarz, H. and Lotz, M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol., 146, 75-85 (1995).
10. Fehsel, K., Kroncke, K.-D., Meyer, K. L., Huber, H., Wahn, V. and Kolb-Bachofen, V. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol., 155, 2858-2865 (1995).
11. Farinelli, S. E., Park, D. S. and Greene, L. A. Nitric oxide delays the death of trophic factor-deprived PC12 cells and synpathetic neurons by a cGMP-mediated mechanism. J. Neurosci., 16, 2325-2334 (1996).
12. Mannick, J. B., Asano, K., Izumi, K., Kieff, E. and Stamler, J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell, 79. 1137-1146 (1994).
13. Dimmeler, S., Haendeler, J., Nehls, M. and Zeiher, A. M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med., 185, 601-607 (1997).
14. Ikeda, I., Ishizaka, Y., Tahira, T., Suzuki, T., Onda, M., Sugimura, T. and Nagao, M. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene, 5, 1291-1296 (1990).
15. Davis, E. G., Dibner, M. D. and Battey, J. F. DNA preparation from cultured cells and tissue. In " Methods in Molecular Biology, " ed. L. G. Davis, M. D. Dibner and J. F. Battey, pp. 44-16 (1986). Elsevier, New York.
16. Enari, M., Talanian, R. V., Wong, W. W. and Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature, 380, 723-726 (1996).
17. Ogura, T., Takenouchi, N., Yamaguchi, M., Matsukage, A., Sugimura, T. and Esumi, H. Striking similarity of the distribution patterns of the poly(ADP-ribose) polymerase and DNA polymerase β among various mouse organs. Biochem. Biophys. Res. Commun., 172, 377-384 (1990).
18. Schmidt, H. H. H. W., Lohmann, S. M. and Walter, U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta, 1178, 153-175 (1993).
19. Chang, Y. F., Li, L. L., Wu, C. W., Liu, T. Y., Lui, W. Y., Peng, F. K. and Chi, C. W. Paclitaxel-induced apoptosis in human gastric carcinoma cell line. Cancer, 77, 14-18 (1996).
20. Danesi, R., Figg, W. D., Reed, E. and Myers, C. E. Paclitaxel (Taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Mol. Pharmacol., 47, 1106-1111 (1995).
21. Havrilesky, L. J., Elbendary, A., Hurteau, L. A., Whitaker, R. S., Rodriguez, G. C. and Berchuck, A. Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet. Gynecol., 85, 1007-1010 (1995).
22. Martin, S. J. and Green, D. R. Protease activation during apoptosis: death by a thousand cuts? Cell, 82, 349-352 (1995).
23. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E. and Poirier, G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53, 3976-3985 (1993).
24. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. and Dixit, V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801-809 (1995).
25. Bender, R. A., Hamel, E. and Hande, K. R. The plant alkaloids. In "Cancer Chemotherapy: Principles and Practice." ed. B. A. Chabner and J. M. Collins, pp. 253-275 (1990). Lippincott, Philadelphia.
26. Burris, H. A., 3rd and Fields, S. Summary of data from in vitro and phase I vinorelbine (Navelbine). Semin. Oncol., 21, 14-19 (1994).
27. Spencer, C. M. and Faulds, D. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs, 48, 794-847 (1994).
28. Fraser, A. and Evan, G. A license to kill. Cell, 85, 781-784 (1996).
29. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542 (1994).
30. Stamler, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell, 78, 931-936 (1994).
31. Ogura, T., Tatemichi, M. and Esumi, H. Nitric oxide inhibits CPP32-like activity under redox regulation. Biochem. Biophys. Res. Commun., 236, 365-369 (1997).
32. Miyashita, T. and Reed, J. C. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52, 5407-5411 (1992).
33. Tang, C., Willingham, M. C., Reed, J. C., Miyashita, T., Ray, S., Ponnathpur, V., Huang, Y., Mahoney, M. E., Bullock, G. and Bhalla, K. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia, 8, 1960-1969 (1994).
34. Liu, X., Kim, C. N., Yang, J., Jemmerson, R. and Wang, X. Induction of apoptosis program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86, 147-157 (1996).
35. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P. and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275, 1129-1132 (1997).
36. Kluck, R. M., Bossy-Wetzel, E., Green, D. R. and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Saence, 275, 1132-1136 (1997).